Sandoz Pushes Back On AMR And ‘Dysfunctional’ Antibiotics Market
Get Access Balance Right And Consider Market Reforms, Urge Senior Executives
Executive Summary
Sandoz CEO Richard Saynor and global head of anti-infectives Ian Ball have spoken out on the threat of antimicrobial resistance and the “increasing dysfunctionality” of the market framework for antibiotics.